The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
North America: Vitamins Market
US$ 1,999.00
... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...
June 2026
150 pages
Pharmaceutical Fine Chemicals Market Forecasts to 2034 – Global Analysis By Product Type (Intermediates, Active Pharmaceutical Ingredients, Building Blocks, Reagents, Solvents, Protecting Agents, Catalysts, Chiral Chemicals, and Other Fine Chemicals), Synthesis Type, Application, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Pharmaceutical Fine Chemicals Market is accounted for $165.9 billion in 2026 and is expected to reach $262.5 billion by 2034 growing at a CAGR of 5.9% during t...
June 2026
200 pages
Pharmaceutical Intermediates Market Forecasts to 2034 – Global Analysis By Product Type (Basic Intermediates, Advanced Intermediates, API Intermediates, Chiral Intermediates, and Specialty Intermediates), Synthesis Type, Therapeutic Area, Application, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Pharmaceutical Intermediates Market is accounted for $234.5 billion in 2026 and is expected to reach $396.9 billion by 2034 growing at a CAGR of 6.8% during th...
June 2026
200 pages
Global Lupus Therapeutic Market Size Study and Forecast by Type (Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, Neonatal Lupus), Treatment (Corticosteroids, Immunosuppressive Drugs, Biologic Drugs, Antihypertensive Drugs, Others), Diagnosis, Route of Administration, End-Users, Regional Forecasts 2026-2036
US$ 3,750.00
The global lupus therapeutic market, valued at USD 3.62 billion in 2025, is anticipated to reach USD 9.44 billion by 2036, growing at 9.10% CAGR during the forecast period. The lupus therapeutic marke...
June 2026
285 pages
Global KSK7653 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global KSK7653 market size is expected to reach $ 321 million by 2032, rising at a market growth of 24.1% CAGR during the forecast period (2026-2032). In 2025, global HSK7653 production reached ap...
June 2026
88 pages
Bleeding Disorders Treatment Market Report by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others), Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), End User (Hospitals, Clinics, Academic and Research Institutes), and Region 2026-2034
US$ 3,999.00
The global bleeding disorders treatment market size reached USD 16.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.3 Billion by 2034, exhibiting a growth rate (CAGR)...
June 2026
144 pages
Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2026-2034
US$ 3,999.00
The global intravenous (IV) ibuprofen market size reached USD 7.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.6 Billion by 2034, exhibiting a growth rate (CAGR) of...
June 2026
149 pages
